WASHINGTON (Reuters) - A drug being developed by Acorda Therapeutics Inc helps some people with multiple sclerosis walk better, an important step in improving their quality of life, U.S. researchers said on Thursday.
WASHINGTON (Reuters) - A drug being developed by Acorda Therapeutics Inc helps some people with multiple sclerosis walk better, an important step in improving their quality of life, U.S. researchers said on Thursday.
